| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 36,337 | 44,127 | ||
| Marketable securities, current | 92,913 | 98,147 | ||
| Prepaid expenses and other current assets | 3,199 | 3,037 | ||
| Total current assets | 132,449 | 145,311 | ||
| Total property and equipment | 1,549 | - | ||
| Less accumulated depreciation | 1,294 | - | ||
| Property and equipment, net | 255 | 287 | ||
| Right-of-use assets | 891 | 977 | ||
| Marketable securities, noncurrent | - | 6,032 | ||
| Other assets | 249 | 248 | ||
| Total assets | 133,844 | 152,855 | ||
| Accounts payable | 3,399 | 2,598 | ||
| Accrued expenses | 8,515 | 8,632 | ||
| Operating lease liabilities, current | 390 | 377 | ||
| Total current liabilities | 12,304 | 11,607 | ||
| Operating lease liabilities, noncurrent | 541 | 643 | ||
| Total liabilities | 12,845 | 12,250 | ||
| Additional paid-in capital | 549,325 | 547,942 | ||
| Accumulated deficit | -428,417 | -407,358 | ||
| Accumulated other comprehensive income | 91 | 21 | ||
| Total stockholders equity | 120,999 | 140,605 | ||
| Total liabilities and stockholders equity | 133,844 | 152,855 | ||
PMV Pharmaceuticals, Inc. (PMVP)
PMV Pharmaceuticals, Inc. (PMVP)